Evidence map›Paper›PMID 24469459›Full record

ArticleThe Journal of biological chemistry2014

Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA.

Christopher D Blackstock, Yusuke Higashi, Sergiy Sukhanov, Shaw-Yung Shai, Branko Stefanovic, A Michael Tabony, Tadashi Yoshida, Patrice Delafontaine

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cobalt complexes in biology and medicine: enzymatic functions, pharmacological applications, and health challenges.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Review
  4. Bone Growth Stimulators to Enhance Spinal Fusion Outcomes.Spine surgery and related research · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biomolecular NMR assignments · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Christopher D BlackstockFrom the Heart and Vascular Institute, and Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112 and.
Yusuke Higashi
Sergiy Sukhanov
Shaw-Yung Shai
Branko Stefanovic
A Michael Tabony
Tadashi Yoshida
Patrice Delafontaine
Tulane University · USFlorida State University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
VASCULAR SMOOTH MUSCLE PLASTICITY IN NITRIC OXIDEP20RR018766 · NCRR · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2003 to 2011
$18.5M
Insulin-Like Growth Factor-1and AtherosclerosisR01HL070241 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI PATRICE DELAFONTAINE · 2003 to 2026
$10.1M
Translational Research in Hypertension and Renal BiologyP30GM103337 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2012 to 2016
$5.8M
ANGIOTENSIN II, IGF-1 AND SKELETAL MUSCLE ATROPHYR01HL080682 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DELAFONTAINE, PATRICE · 2007 to 2015
$3.3M
MENTORING IN CARDIOVASCULAR BIOLOGYP20GM103514 · NIGMS · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2012 to 2012
$2.0M
12/15-LIPOXYGENASE, INSULIN-LIKE GROWTH FACTOR-1 AND ATHEROSCLEROSISR21HL113705 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SUKHANOV, SERGIY · 2013 to 2014
$399k
NCRR NIH HHS P20 RR018766NCRR NIH HHS P20-RR018766NHLBI NIH HHS R01 HL070241NHLBI NIH HHS R01-HL070241NHLBI NIH HHS R01 HL080682NHLBI NIH HHS R01-HL080682NHLBI NIH HHS R21 HL113705NHLBI NIH HHS R21-HL113705-01A1NIGMS NIH HHS P20 GM103514NIGMS NIH HHS P20-GM103514NIGMS NIH HHS P30 GM103337NIGMS NIH HHS P30-GM103337NIGMS NIH HHS U54 GM104940NIGMS NIH HHS U54-GM104940
6 · The paper itself

Abstract

Collagen content in atherosclerotic plaque is a hallmark of plaque stability. Our earlier studies showed that insulin-like growth factor-1 (IGF-1) increases collagen content in atherosclerotic plaques of Apoe(-/-) mice. To identify mechanisms we investigated the effect of IGF-1 on the la ribonucleoprotein domain family member 6 (LARP6). LARP6 binds a stem-loop motif in the 5'-UTR of the mRNAs encoding the collagen type I α-subunits (α1(I) and α2(I)), and coordinates their translation into the heterotrimeric collagen type I molecule. In human aortic smooth muscle cells (SMCs), IGF-1 rapidly increased LARP6 expression and the rate of collagen synthesis and extracellular accumulation. IGF-1 increased both LARP6 and collagen type I expression via a post-transcriptional and translation-dependent mechanism involving PI3K/Akt/p70S6k-signaling. Immunoprecipitation of LARP6, followed by qPCR indicated that IGF-1 increased the level of COL1a1 and COL1a2 mRNA bound to LARP6. Mutation of the 5' stem-loop of Col1a1 mRNA, which inhibits binding of LARP6, abolished the ability of IGF-1 to increase synthesis of collagen type I. Furthermore, overexpression of a 5' stem-loop RNA molecular decoy that sequesters LARP6, prevented the ability of IGF-1 to increase pro-α1(I) and mature α1(I) expression in cultured medium. IGF-1 infusion in Apoe(-/-) mice increased expression of LARP6 and pro-α1(I) in aortic lysates, and SMC-specific IGF-1-overexpression robustly increased collagen fibrillogenesis in atherosclerotic plaque. In conclusion, we identify LARP6 as a critical mediator by which IGF-1 augments synthesis of collagen type I in vascular smooth muscle, which may play an important role in promoting atherosclerotic plaque stability.

Indexed as

Gene Expression RegulationAnimalsAortaAtherosclerosisAutoantigensCells, CulturedCollagen Type ICollagen Type I, alpha 1 ChainHumansInsulin-Like Growth Factor IMiceMice, Inbred C57BLMice, TransgenicMuscle, SmoothMutationMyocytes, Smooth MuscleAutoantigensCollagen Type ICollagen Type I, alpha 1 ChainIGF1 protein, humaninsulin-like growth factor-1, mouseInsulin-Like Growth Factor IRibonucleoproteinsRNA, MessengerSS-B Antigen5′ Stem-loopAcheronAktAtherosclerosisFibrillogenesisInsulin-like Growth Factor (IGF)Post-transcriptionalProtein SynthesisTranslationVascular Smooth Muscle Cells

Identifiers

PMID24469459
PMCPMC3953245
OpenAlexW2051147675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.